Unimarck Pharma a third-party pharma manufacturing company has faced several challenges to become a success story in this industry in the recent years . One massive need was to uphold high quality on every level. To counter this, Unimarck set up modern production lines and effective quality assurance measures to ensure it produced high quality goods.
There was also a challenge of dealing with the various regulatory measures as they are sometimes complicated depending on the area of jurisdiction. What Unimarck did was to gain a universal knowledge of the laws governing international business, and then modify their system to suit these laws, making it convenient for them to deal with both the domestic and international market.
Another problem that affected many companies was the supply chain risks: Disruptions, in particular due to the COVID-19 pandemic, were another major concern. Unimarck countered this by sourcing from several different suppliers and developing close partnerships with their trusted sources of raw materials.
Also, there are hunger for market share which makes competition in the pharma industry cut throat. A major strategy that Unimarck adopted was power, sales and innovation, where they were committed to customizing solutions that met the needs of their clientele.
Having crossed such hurdles, Unimarck Pharma has carved a niche for itself in third-party pharmaceutical manufacturing services.